Holen Sie sich die Stockscreener-App
183.83
1.20%
2.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$181.65
Offen:
$183.9
24-Stunden-Volumen:
126.84K
Relative Volume:
0.58
Marktkapitalisierung:
$3.62B
Einnahmen:
$152.42M
Nettoeinkommen (Verlust:
$45.24M
KGV:
73.24
EPS:
2.51
Netto-Cashflow:
$6.97M
1W Leistung:
-3.47%
1M Leistung:
-2.62%
6M Leistung:
+17.84%
1J Leistung:
+61.35%
1-Tages-Spanne:
$182.63
$186.74
1-Wochen-Bereich:
$179.20
$191.74
52-Wochen-Spanne:
$93.58
$212.49
Ligand Pharmaceuticals Inc Stock (LGND) Company Profile
Firmenname
Ligand Pharmaceuticals Inc
Sektor
Branche
Telefon
858-550-7500
Adresse
3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA
Compare LGND vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LGND
Ligand Pharmaceuticals Inc
|
183.83 | 3.58B | 152.42M | 45.24M | 6.97M | 2.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Citigroup | Buy |
| 2025-04-10 | Eingeleitet | Stifel | Buy |
| 2024-10-03 | Eingeleitet | Oppenheimer | Outperform |
| 2024-07-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-04-14 | Fortgesetzt | Stephens | Overweight |
| 2021-02-04 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-06 | Eingeleitet | Barclays | Overweight |
| 2020-03-24 | Herabstufung | Argus | Buy → Hold |
| 2020-03-10 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-06 | Eingeleitet | The Benchmark Company | Buy |
| 2019-09-19 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2019-06-11 | Eingeleitet | Barclays | Equal Weight |
| 2019-05-03 | Bestätigt | H.C. Wainwright | Buy |
| 2019-03-06 | Bestätigt | H.C. Wainwright | Buy |
| 2018-10-29 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-11 | Bestätigt | Argus | Buy |
| 2018-08-17 | Eingeleitet | Goldman | Neutral |
| 2018-08-08 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2018-06-21 | Eingeleitet | Argus | Buy |
| 2017-12-27 | Bestätigt | H.C. Wainwright | Buy |
| 2017-09-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2016-10-05 | Bestätigt | H.C. Wainwright | Buy |
| 2016-08-05 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2016-03-11 | Eingeleitet | Sidoti | Buy |
| 2016-03-03 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Ligand Pharmaceuticals Inc Aktie (LGND) Neueste Nachrichten
Cibc World Market Inc. Increases Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Is Ligand Pharmaceuticals Incorporated in a long term uptrend2025 Major Catalysts & Capital Efficiency Focused Ideas - mfd.ru
Ligand Pharmaceuticals Announces Fourth Quarter and Full Year 2025 Financial Results Call Scheduled for February 26, 2026 - Quiver Quantitative
Biopharma company Ligand to reveal 2025 results Feb. 26 - Stock Titan
Is Ligand Pharmaceuticals Incorporated subject to activist investor interest2025 Big Picture & Reliable Entry Point Trade Alerts - mfd.ru
Should I buy Ligand Pharmaceuticals Incorporated stock nowJuly 2025 Sector Moves & Capital Efficiency Focused Strategies - mfd.ru
Why Ligand Pharmaceuticals Incorporated stock is a must watch in 2025Profit Target & Stepwise Trade Signal Guides - mfd.ru
Impax Asset Management Group plc Sells 60,000 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Principal Financial Group Inc. Sells 7,210 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Trend Review: Is AMRN a cyclical or defensive stockQuarterly Trade Report & Safe Capital Investment Plans - baoquankhu1.vn
Ranger Investment Management L.P. Has $48.77 Million Stake in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), AbbVie (ABBV) and Bio-Techne (TECH) - The Globe and Mail
Ligand Pharmaceuticals (LGND) director sells $91k in stock By Investing.com - Investing.com India
Ligand Pharmaceuticals (LGND) director sells $91k in stock - Investing.com
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus
Ligand Pharmaceuticals (LGND) Valuation Check As Partner Milestones Expand Royalty And Growth Potential - simplywall.st
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - Yahoo Finance
Ligand Pharmaceuticals (NASDAQ:LGND) Director John Kozarich Sells 467 Shares - MarketBeat
LGND: New Year Program Updates - Zacks Small Cap Research
Villere ST Denis J & Co. LLC Has $49.59 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
New York State Common Retirement Fund Decreases Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Growth Value: Whats next for Global Business Travel Group Inc stockBuy Signal & Weekly High Potential Stock Alerts - baoquankhu1.vn
Earnings Update: Should you avoid IKNA stock right nowJuly 2025 Pullbacks & Technical Pattern Alert System - baoquankhu1.vn
Published on: 2026-02-02 03:00:22 - baoquankhu1.vn
Lisanti Capital Growth LLC Boosts Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Surprises Report: Can TZOO weather a recessionIndex Update & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Acuitas Investments LLC Purchases 382,597 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Whale Trades: What is the dividend yield of Ligand Pharmaceuticals IncorporatedJuly 2025 Pullbacks & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Can Ligand Pharmaceuticals Incorporated outperform in the next rallyWeekly Stock Report & Entry Point Confirmation Signals - mfd.ru
Breakout Watch: Whats the profit margin of Ligand Pharmaceuticals IncorporatedMarket Rally & AI Driven Stock Movement Reports - baoquankhu1.vn
7,200 Shares in Ligand Pharmaceuticals Incorporated $LGND Acquired by Pier 88 Investment Partners LLC - MarketBeat
Is Ligand Pharmaceuticals Incorporated in a bullish channelBull Run & AI Enhanced Execution Alerts - mfd.ru
Aug Opening: Can KRUS benefit from deglobalizationJuly 2025 Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn
Pullback Watch: Is Ligand Pharmaceuticals Incorporated a stock for growth or value investors2025 Pullback Review & Capital Efficiency Focused Ideas - baoquankhu1.vn
Massachusetts Financial Services Co. MA Buys 202,103 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Stephens Investment Management Group LLC Sells 50,271 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
SG Americas Securities LLC Has $2.08 Million Stock Position in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Could Be 37% Below Their Intrinsic Value Estimate - Yahoo Finance UK
Travere, Ligand Hammered On A Surprise Delay For Their Linchpin Drug - Investor's Business Daily
Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13 - TechStock²
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap DownShould You Sell? - MarketBeat
Patterns Watch: Can Ligand Pharmaceuticals Incorporated stock continue upward trendJuly 2025 Breakouts & Safe Capital Growth Plans - Bộ Nội Vụ
Published on: 2026-01-13 22:28:13 - Bộ Nội Vụ
Gamble on Huge Gains with These 3 Best Biotech Stocks to Buy for 2026 - Yahoo Finance
Can Ligand Pharmaceuticals Incorporated stock rebound after recent weaknessJuly 2025 Fed Impact & Safe Entry Zone Tips - Улправда
Will Ligand Pharmaceuticals Incorporated stock remain a Wall Street favoriteTrade Risk Assessment & Daily Risk Controlled Trade Plans - Улправда
What technical signals suggest for Ligand Pharmaceuticals Incorporated stockJuly 2025 EndofMonth & High Win Rate Trade Tips - Улправда
Is Ligand Pharmaceuticals Incorporated stock attractive for hedge fundsQuarterly Trade Report & Entry Point Confirmation Signals - ulpravda.ru
Is Ligand Pharmaceuticals Incorporated stock a top momentum playExit Point & Free Long-Term Investment Growth Plans - Улправда
Is Ligand Pharmaceuticals Incorporated (LGDN) stock positioned for digital growth eraMarket Performance Summary & Weekly High Return Opportunities - Улправда
Finanzdaten der Ligand Pharmaceuticals Inc-Aktie (LGND)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):